Predicting the public health benefit of vaccinating cattle against Escherichia coli O157
Open Access
- 16 September 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (40), 16265-16270
- https://doi.org/10.1073/pnas.1304978110
Abstract
Identifying the major sources of risk in disease transmission is key to designing effective controls. However, understanding of transmission dynamics across species boundaries is typically poor, making the design and evaluation of controls particularly challenging for zoonotic pathogens. One such global pathogen is Escherichia coli O157, which causes a serious and sometimes fatal gastrointestinal illness. Cattle are the main reservoir for E. coli O157, and vaccines for cattle now exist. However, adoption of vaccines is being delayed by conflicting responsibilities of veterinary and public health agencies, economic drivers, and because clinical trials cannot easily test interventions across species boundaries, lack of information on the public health benefits. Here, we examine transmission risk across the cattle–human species boundary and show three key results. First, supershedding of the pathogen by cattle is associated with the genetic marker stx2. Second, by quantifying the link between shedding density in cattle and human risk, we show that only the relatively rare supershedding events contribute significantly to human risk. Third, we show that this finding has profound consequences for the public health benefits of the cattle vaccine. A naïve evaluation based on efficacy in cattle would suggest a 50% reduction in risk; however, because the vaccine targets the major source of human risk, we predict a reduction in human cases of nearly 85%. By accounting for nonlinearities in transmission across the human–animal interface, we show that adoption of these vaccines by the livestock industry could prevent substantial numbers of human E. coli O157 cases.Keywords
This publication has 42 references indexed in Scilit:
- Assessing the Existing Information on the Efficacy of Bovine Vaccination against Escherichia coli O157:H7 – A Systematic Review and Meta‐analysisZoonoses and Public Health, 2012
- A Systematic Review of Vaccinations to Reduce the Shedding of Escherichia coli O157 in the Faeces of Domestic RuminantsZoonoses and Public Health, 2011
- Exploiting strain diversity to expose transmission heterogeneities and predict the impact of targeting supersheddingEpidemics, 2009
- Shiga Toxin Produced by Enterohemorrhagic Escherichia coli Inhibits PI3K/NF-κB Signaling Pathway in Globotriaosylceramide-3-Negative Human Intestinal Epithelial CellsPublished by The American Association of Immunologists ,2007
- Risk Factors for the Presence of High-Level Shedders of Escherichia coli O157 on Scottish FarmsJournal of Clinical Microbiology, 2007
- Human Benefits of Animal Interventions for Zoonosis ControlEmerging Infectious Diseases, 2007
- Escherichia coli O157: Burger bug or environmental pathogen?International Journal of Food Microbiology, 2006
- Super-shedding cattle and the transmission dynamics ofEscherichia coliO157Epidemiology and Infection, 2005
- Shiga Toxin–ProducingEscherichia coliin Montana: Bacterial Genotypes and Clinical ProfilesThe Journal of Infectious Diseases, 2003
- Options for the control of enterohaemorrhagic Escherichia coli in ruminantsMicrobiology, 2002